Skye Bioscience, Inc. Quarterly Depreciation, Depletion and Amortization in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Skye Bioscience, Inc. quarterly Depreciation, Depletion and Amortization history and growth rate from Q1 2013 to Q3 2024.
  • Skye Bioscience, Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $47.5K, a 272% increase year-over-year.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $47.5K +$34.7K +272% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q3 2023 $12.8K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2013 $3.85K May 1, 2013 Jul 31, 2013 10-Q 2013-09-16
Q1 2013 $3.85K Jan 31, 2013 Apr 30, 2013 10-Q 2013-06-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.